r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

AM

Anne McGeorge

Insider · Director · DNTH

Anne McGeorge files insider transactions with the SEC as a director of Dianthus Therapeutics, Inc. /DE/ (DNTH). We hold 1 disclosed purchase or sale filed since 24 June 2019, 1 of them in the last 90 days.

  • Files forDNTH
  • Disclosed buys and sells1 in all, 1 in the last 90 days
  • Last disclosure11 August 2026

Positions held

4 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 11 September 2023 — 10 August 2026Director · Dianthus Therapeutics, Inc. /DE/ (DNTH)13 Form 4 lines · source: SEC Form 4
  • Filed 21 March 2022 — 27 July 2026Director · Oncology Institute (TOI)9 Form 4 lines · source: SEC Form 4
  • Filed 20 June 2019 — 28 June 2022Director · Magenta Therapeutics (MGTA)4 Form 4 lines · source: SEC Form 4
  • Filed 5 January 2021 — 6 April 2022Other role · SOC Telemed (TLMD)3 Form 4 lines · source: SEC Form 4

Everything they disclosed

29 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.